Board Meeting27 Jul 2026, 03:32 pm
Senores Pharma Board Approves Q1 FY27 Unaudited Financial Results
AI Summary
Senores Pharmaceuticals Limited announced that its Board of Directors has approved the unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. The company also informed about the appointment of Ms. Anjali Shah as Assistant Vice President-Finance and Senior Management Personnel, effective July 27, 2026. The financial results and a media release have been submitted to the exchange and are available on the company's website. The Board meeting commenced at 01:45 PM IST and concluded at 02:55 PM IST.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Financial results include consolidated and standalone statements.
- Ms. Anjali Shah appointed as Senior Management Personnel.
- Appointment effective from July 27, 2026.
- Limited Review Reports from statutory auditors are enclosed.
Price Impact
More from SENORES